TOBII DYNAVOX AB (PUBL) (TDVXF)

Saturday

3:48 AM

Thesis: Recent strategic partnerships and product innovations are expected to enhance market presence and drive revenue growth, shifting investor sentiment positively.

Revenue Outlook

Metric	FY2025	FY2026E	FY2027E
Revenue	$2.5B	$2.8B	$3.3B
Rev. Growth	+25.1%	+13.8%	+18.5%
EPS	$1.57	$3.02	$4.22
EPS Growth	+12.9%	+92.6%	+39.4%
P/E (fwd)	4.4×	2.3×	1.6×

★ Analysts see FY2027 revenue reaching $3.3B — +18.5% growth in a single year.

The Bull Case for Growth

1Recent partnerships with major healthcare providers could increase market penetration by 20% over the next year.
2Launch of a new eye-tracking software that improves user experience and is expected to drive a 15% increase in sales.
3Potential regulatory changes could expand funding for assistive technology, positively impacting revenue growth.
4Increased focus on accessibility and inclusion in technology
5Growth in telehealth services and remote patient monitoring
6Changes in healthcare policy affecting funding for assistive devices
7Advancements in eye-tracking technology and product innovation
8Market expansion efforts in emerging markets

FY2025 Snapshot

Revenue: $2.5B
Rev. Growth: +25.1%
Gross Margin: 68.4%
Op. Margin: 10.3%
Net Margin: 6.7%
Net Income: $166M
NI Growth: +13.7%
EPS: $1.57
1Y Return: -38.5%

TDVXF Chart

My Notes

"We're excited about the potential of our new partnerships to significantly expand our reach in the assistive technology market."
Moat: Tobii Dynavox's competitive advantage is reinforced by its strong brand recognition and proprietary technology…
growth - Investors are likely attracted to Tobii Dynavox due to its strong revenue growth potential and innovative product offerings.
Interest rates can affect the company's cost of capital and financing for R&D…
Watch on earnings: Assistive technology market growth rate, R&D expenditure as a percentage of revenue, Customer acquisition cost.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $2.8B to $3.3B as recent partnerships with major healthcare providers could increase market penetration by 20% over the next year.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research note…

First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.